Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Total Liabilities (2010 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Total Liabilities came in at $698595.0 in Q2 2026, up 151.62% year-over-year from $277644.0 in Q2 2025, and up 127.08% quarter-over-quarter from $307649.0 in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Total Liabilities (2010 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Total Liabilities for 17 consecutive years, with $698595.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities rose 151.62% year-over-year to $698595.0 in Q2 2026; TTM through Jun 2026 was $698595.0, a 151.62% increase from a year earlier, with the FY2025 full-year figure at $284880.0, down 13.05% from the prior year.
  • Total Liabilities was $698595.0 for Q2 2026 at Creative Medical Technology Holdings, up from $307649.0 in the prior quarter.
  • Over five years, Total Liabilities peaked at $3.3 million in Q4 2022 and troughed at $261353.0 in Q3 2025.
  • A 5-year average of $534950.3 and a median of $378033.5 in 2022 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities surged 216.21% in 2022 and sank 88.82% in 2023, its largest moves.
  • Over 5 years, Total Liabilities stood at $3.3 million in 2022, then slumped by 88.82% to $371394.0 in 2023, then declined by 11.78% to $327644.0 in 2024, then fell by 13.05% to $284880.0 in 2025, then jumped by 145.22% to $698595.0 in 2026.
  • The last three Total Liabilities figures came in at $698595.0 (Q2 2026), $307649.0 (Q1 2026), and $284880.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 141.52 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 904.22 Mn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 179.49 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 521.30 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 661.05 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 318.91 Mn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 126.72 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 1.66 Bn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 132.83 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 698,595.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 698,595.00
Mar 31, 2026 307,649.00
Dec 31, 2025 284,880.00
Sep 30, 2025 261,353.00
Jun 30, 2025 277,644.00
Mar 31, 2025 286,387.00
Dec 31, 2024 327,644.00
Sep 30, 2024 330,908.00
Jun 30, 2024 376,272.00
Mar 31, 2024 390,959.00
Dec 31, 2023 371,394.00
Sep 30, 2023 421,159.00
Jun 30, 2023 398,527.00
Mar 31, 2023 407,536.00
Dec 31, 2022 3.32 Mn
Sep 30, 2022 396,957.00
Jun 30, 2022 389,795.00
Mar 31, 2022 379,795.00
Dec 31, 2021 1.05 Mn
Sep 30, 2021 3.50 Mn